Amylou C. Dueck

Jun 26, 2024 | nature.com | Charles S. Cleeland |Karen Keating |Jonathan M. Siegel |Christoph Gerlinger |Jeff Sloan |Amylou C. Dueck | +5 more

AbstractWe developed a composite symptom score (CSS) representing disease-related symptom burden over time in patients with malignant pleural mesothelioma (MPM). Longitudinal data were collected from an open-label Phase IIB study in which 239 patients completed the validated MD Anderson Symptom Inventory for MPM (MDASI-MPM). A blinded, independent review committee of external patient-reported outcomes experts advised on MDASI-MPM symptoms to include in the CSS.